Dashboard
Manage Tickers

FRTYAlger Mid Cap 40 ETF


$ 16.53 $ 0.08 (0.52 %)    

Monday, 16-Sep-2024 13:19:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 16.525
$ 16.53
$ 16.34 x 134
-- x --
$ 16.53 - $ 16.53
$ 11.30 - $ 17.85
58,944
na
na
$ 1.25
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vertivs-focus-on-ai-drives-q2-revenue-and-profit-growth-guidance-boost--more
Vertiv's Focus On AI Drives Q2 Revenue and...
07/24/2024 17:03:34

Vertiv Holdings reported strong Q2 FY24 results with 57% organic orders growth, 13% net sales growth, and 63% operating profit ...

saia-upgraded-to-buy-analyst-sees-long-term-opportunity-amid-industry-tailwinds
Saia Upgraded To Buy: Analyst Sees Long-Te...
05/24/2024 18:09:27

Stifel analyst upgrades SAIA to Buy, reduces price target, citing recent performance. Sees potential for growth in LTL industry.

Core News & Articles
Alger Mid Cap 40 ETF Shares Halted On Circ...
04/20/2021 17:28:59

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION